RJA
FRX

Raymond James & Associates’s FOREST LABORATORIES INC FRX Stock Holding History

Raymond James & Associates’s Portfolio FRX Stock Details FRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-268,102
Closed -$26.5M – 2315
2014
Q2 		$26.5M Buy
268,102
+32,136
+14% +$3M 0.16% 118
2014
Q1 		$21.8M Sell
235,966
-18,234
-7% -$1.47M 0.15% 142
2013
Q4 		$15.3M Buy
254,200
+43,233
+20% +$2.18M 0.11% 189
2013
Q3 		$9.03M Buy
210,967
+22,381
+12% +$972K 0.08% 289
2013
Q2 		$7.73M Buy
+188,586
New +$7.29M 0.07% 308

Other funds holding FRX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return
OFG
OTA Financial Group Purchase, New York $143M AUM 16.9% 1-Year Est. Return
KRSITF
Kentucky Retirement Systems Insurance Trust Fund Frankfort, Kentucky $1.47B AUM 27.58% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $1.87B AUM 29.51% 1-Year Est. Return

Raymond James & Associates's FRX Position: Q3 2014 in Review

Raymond James & Associates sold out of FOREST LABORATORIES INC (FRX) in Q3 2014, closing a stake of 268,102 shares — an estimated $26.5M sold.

Raymond James & Associates first reported a position in FRX in Q2 2013 and held it in 5 quarters. The position peaked at $26.5M in Q2 2014. 5 funds tracked by Wall St. Rank hold FRX as of Q3 2014.

  • Raymond James & Associates reported no remaining FOREST LABORATORIES INC position as of Q3 2014 after selling out during the quarter.
  • Raymond James & Associates sold 268,102 FOREST LABORATORIES INC shares in Q3 2014, an estimated $26.5M.
  • Raymond James & Associates first reported a position in FOREST LABORATORIES INC in Q2 2013 and held it in 5 quarters.
  • Raymond James & Associates's FOREST LABORATORIES INC position peaked at $26.5M in Q2 2014.
  • 5 funds tracked by Wall St. Rank held FOREST LABORATORIES INC as of Q3 2014.

Based on Raymond James & Associates's 13F filing for Q3 2014, filed 14 Nov 2014.